Skip to content

BLOOMIOS, INC.

company.status.inactive

CIK 1138608fmd_193QB8SS3SN1S44M4KRFMW2RFBManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard

Coverage: Jan 01, 2018 to Sep 30, 2023, 28 periods

Latest annual · FY2022

Millions
Total revenues
6
Gross profit
2
Operating income
(4)
Net income
(14)

Latest quarter · Q3 FY2023

Millions
Total revenues
1
Gross profit
0
Operating income
(1)
Net income
(26)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2020 to FY2022
n/m
Revenue, 5 yearsFY2019 to FY2022
n/m
Net income, 5 yearsFY2019 to FY2022
n/m

BLOOMIOS, INC. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2022FY2021ChangeSource
Revenue$6.1 million$8.5 million-28.4%10-K 2023-04-17 · proof
Gross profit$2.2 million$3.8 million-41.1%10-K 2023-04-17 · proof
Operating income-$4.1 million-$800,47810-K 2023-04-17 · proof
Net income-$13.8 million-$2 million10-Q 2023-05-18 · proof
Cash from operating activities-$6.3 million-$98,51910-K 2023-04-17 · proof
Total assets$26 million$4 million+549.1%10-K 2023-04-17 · proof
Total liabilities$27.3 million$5.6 million+390.1%10-K 2023-04-17 · proof
Cash and cash equivalents$0$270,515-100%10-K 2023-04-17 · proof
What was BLOOMIOS, INC.'s revenue in fiscal 2022?
BLOOMIOS, INC. reported revenue of $6.1 million for fiscal 2022 (the year ended Dec 31, 2022), against $8.5 million the year before (-28.4%). Source: the 10-K filed with the SEC on Apr 17, 2023. SEC
What was BLOOMIOS, INC.'s gross profit in fiscal 2022?
BLOOMIOS, INC. reported gross profit of $2.2 million for fiscal 2022 (the year ended Dec 31, 2022), against $3.8 million the year before (-41.1%). Source: the 10-K filed with the SEC on Apr 17, 2023. SEC
What was BLOOMIOS, INC.'s operating income in fiscal 2022?
BLOOMIOS, INC. reported operating income of -$4.1 million for fiscal 2022 (the year ended Dec 31, 2022), against -$800,478 the year before. Source: the 10-K filed with the SEC on Apr 17, 2023. SEC
What was BLOOMIOS, INC.'s net income in fiscal 2022?
BLOOMIOS, INC. reported net income of -$13.8 million for fiscal 2022 (the year ended Dec 31, 2022), against -$2 million the year before. Source: the 10-Q filed with the SEC on May 18, 2023 (restated). SEC
What was BLOOMIOS, INC.'s cash from operating activities in fiscal 2022?
BLOOMIOS, INC. reported cash from operating activities of -$6.3 million for fiscal 2022 (the year ended Dec 31, 2022), against -$98,519 the year before. Source: the 10-K filed with the SEC on Apr 17, 2023. SEC
What are BLOOMIOS, INC.'s total assets?
As of Dec 31, 2022, BLOOMIOS, INC. reported total assets of $26 million, against $4 million a year earlier (+549.1%). Source: the 10-K filed with the SEC on Apr 17, 2023. SEC
What are BLOOMIOS, INC.'s total liabilities?
As of Dec 31, 2022, BLOOMIOS, INC. reported total liabilities of $27.3 million, against $5.6 million a year earlier (+390.1%). Source: the 10-K filed with the SEC on Apr 17, 2023. SEC
What are BLOOMIOS, INC.'s cash and cash equivalents?
As of Dec 31, 2022, BLOOMIOS, INC. reported cash and cash equivalents of $0, against $270,515 a year earlier (-100%). Source: the 10-K filed with the SEC on Apr 17, 2023. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1138608&period_type=annual&limit=5"

Information only, not investment advice.